RA CAPITAL MANAGEMENT, L.P. bought VOR

September 18, 2025 · Form 4 insider transaction

RA CAPITAL MANAGEMENT, L.P. bought 10,000,000 shares of Vor Biopharma Inc. at $5.00 per share, a transaction worth $50.00M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
10,000,000
Price
$5.00
Total value
$50.00M
RoleDirector, 10% owner
SecurityPre-Funded Warrant (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 18, 2025
Filing dateSeptember 22, 2025
Shares owned after10,000,000
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The Pre-Funded Warrants were originally acquired on June 27, 2025. Upon issuance, the Pre-Funded Warrants were not exercisable for common stock until the Issuer's stockholders approved the issuance of the common stock issuable upon exercise of the Pre-Funded Warrants and the effectiveness of an amendment to the Issuer's certificate of incorporation (the "Exercisability Condition"). Because of the Exercisability Condition, the Pre-Funded Warrants were not considered derivative securities and were, therefore, not reportable under Section 16 of the Securities Exchange Act, until such condition was satisfied. The Exercisability Condition was satisfied on September 18, 2025.; Upon satisfaction of the Exercisability Condition, the Pre-Funded Warrants became exercisable for common stock at any time at the option of the holder. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Pre-Funded Warrants to the extent that such exercise would cause the aggregate number of shares of common stock beneficially owned by the Reporting Persons, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 9.99% of the total number of issued and outstanding shares of common stock of the Issuer following such exercise.; The Pre-Funded Warrants have no expiration date.; RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.; Held directly by the Fund.

View the original Form 4 on SEC EDGAR
RA CAPITAL MANAGEMENT, L.P. bought VOR: September 18, 2025 | Insider Trading Screener